Lyka Labs Ltd.

View in App
112.90 -0.05 ▼0.0%

25 September 2023, 04:01:00 PM
Volume: 3,382

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lykalabs.com
Market Cap 374.08 Cr.
Enterprise Value(EV) 434.55 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -4.73 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 37.43 Trailing Twelve Months Ending 2023-06
Book Value / Share 18.00 Trailing Twelve Months Ending 2023-06
Price to Book Value 6.27 Calculated using Price: 112.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.31 Cr. 33,090,000 Shares
FaceValue 10
About Lyka Labs Ltd.
Lyka Labs Ltd was incorporated on December 29, 1976 as a private limited company and converted into a public limited company on December 19, 1985.

Lyka Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Lyka Labs Ltd. Performance

View details >>
1 Day
-0.04%
1 Week
-0.48%
1 Month
-1.83%
3 Month
-4.73%
6 Month
+3.86%
1 Year
-16.99%
2 Year
+29.18%
5 Year
+190.23%
10 Year
+1074.82%

Lyka Labs Ltd. Fundamental Ratios

View details >>
9 years 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -13.05 11.74 -18.27 -46.30 -14.20 -448.65 -63.63
Return on Capital Employed (%) 11.73 12.41 6.66 -6.52 -5.50 -31.39 8.95 56.68 -1.00
Return on Assets (%) -1.55 1.58 -2.70 -8.02 -2.97 -32.05 -5.58 21.40 -7.80

Lyka Labs Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 53 43 45 38 49 43 -14 -26 13 45
Non Curr. Liab. 65 37 29 39 5 72 137 149 73 73
Curr. Liab. 208 195 163 165 167 85 66 50 99 33
Minority Int. 3 4 4 7 3 3 -1 1 0 0
Equity & Liab. 329 279 241 249 225 203 188 174 186 152
Non Curr. Assets 211 177 159 186 176 168 152 145 133 107
Curr. Assets 118 102 82 63 49 35 36 29 52 44
Misc. Exp. not W/O
Total Assets 329 279 241 249 225 203 188 174 186 152

Lyka Labs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 166 130 110 60 71 61 86 194 93 88
Other Income 2 2 2 2 2 3 2 2 3 3
Total Income 169 132 112 62 73 65 88 196 96 92
Total Expenditure -138 -110 -87 -63 -73 -65 -67 -93 -76 -75
PBIDT 31 22 25 -1 0 -1 21 103 20 16
Interest -26 -16 -19 -10 -7 -20 -26 -20 -12 -10
Depreciation -11 -9 -10 -11 -7 -8 -8 -17 -14 -14
Taxation -1 0 2 1 9 -1 4 -21 0 0
Exceptional Items 2 7 -4 2 -1 -33 -1 -7 -7 -8
PAT -5 4 -7 -19 -6 -63 -10 38 -13 -16
Minority Interest 0 0 1 2 1 2 -1 1 0 0
Share Associate
Other Related Items
Consolidated Net Profit -5 4 -6 -17 -6 -61 -12 39 -13 -16
Adjusted EPS -2 2 -3 -6 -2 -21 -4 14 -4 -5

Lyka Labs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 89 27 12 31 11 27 5 9 79 9
Cash Fr. Inv. -57 29 17 -13 -3 -4 0 0 -6 7
Cash Fr. Finan. -26 -60 -30 -19 -10 -23 3 -12 -63 -22
Net Change 6 -4 -1 0 -3 -1 9 -3 10 -5
Cash & Cash Eqvt 11 7 6 5 2 2 10 7 17 12

Lyka Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 19.88 20.00 20.04 47.79 47.80 47.59 47.59 51.00 54.58
Public 80.12 80.00 79.96 52.21 52.20 52.41 52.41 49.00 45.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 26.76 17.95 16.98 7.12 5.53 5.12 5.12 0.00 0.00

Lyka Labs Ltd. Announcements

View details >>
Mon, 25 Sep 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kunal Gandhi & PACs
Mon, 25 Sep 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Enai Trading & Investment Pvt Ltd & PACs
Mon, 25 Sep 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nehal N Gandhi & PACs

Lyka Labs Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 5 Years High Increase in 5 Years

Lyka Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,697.25 1,124.05 -0.7%
Divi's Laboratories Ltd. 99,021.11 3,730.05 +0.6%
Cipla Ltd. 95,166.58 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. 90,720.90 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. 73,268.35 5,095.45 +2.2%
Mankind Pharma Ltd. 69,694.38 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. 62,519.33 1,844.85 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.97 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 67.03 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 30.62 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.21 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.58 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 54.37 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.55 1,844.85 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 7.55 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 3.91 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.68 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.49 1,844.85 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,844.85 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,844.85 -0.3%

Lyka Labs Ltd. FAQ's

What is Lyka Labs share price?
Can I buy Lyka Labs shares now?
What is the Market Cap of Lyka Labs?
What are the key metrics to analyse Lyka Labs?
What is the 52 Week High and Low of Lyka Labs?
What is the trend of Lyka Labs share price?